How metformin affects various malignancies by means of microRNAs: a brief review

How metformin affects various malignancies by means of microRNAs: a brief review

Abstract Metformin known as the first-line orally prescribed drug for lowering blood glucose in type II diabetes (T2DM) has recently found various therapeutic applications including in cancer. Metformin has been studied for its influences in prevention and treatment of cancer through multiple mechan...

Full description

Bibliographic Details
Main Authors: Nahid Alimoradi, Negar Firouzabadi, Reihaneh Fatehi
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Cancer Cell International
Subjects:
Metformin
MicroRNAs
Cancer
AMPK
Biomarker
Mechanism of action
Online Access:https://doi.org/10.1186/s12935-021-01921-z

Similar Items

Similar Items